Literature DB >> 426498

Antiviral and interferon-inducing properties of 1,5-diamino anthraquinones.

D A Stringfellow, S D Weed, G E Underwood.   

Abstract

A series of anthraquinones with amino substituents at the 1,5 positions were found to induce interferon in mice. A prototype compound, 1,5-bis[(3-morpholinopropyl)amino]-anthraquinone (Ia), was an effective antiviral agent when administered either orally or parenterally. Peak interferon titers were found 12 to 24 h after drug treatment. The minimum oral dose of Ia required to induce serum interferon or to protect mice against a lethal virus infection was 62 mg/kg. Mice tolerated an oral dose of at least 30 times this minimum effective dose. A single dose of Ia given up to 6 days prior to infection had significant protective activity. Biological properties of Ia were compared with those of three other 1,5-diamino anthraquinones, which also induced interferon and demonstrated antiviral activity in mice. The most active compound was 1,5-bis[[2-(diethylamino)ethyl]amino]-anthraquinone (Ib), which protected mice against virus infection at a dose as low as 8 mg/kg (less than 1/60 its maximum tolerated dose). Mice developed hyporeactivity to interferon induction if the same inducer was injected daily, although by alternating between different inducers the loss of interferon responsiveness could be avoided.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426498      PMCID: PMC352608          DOI: 10.1128/AAC.15.1.111

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  INTERFERON REDUCTION IN CHICKENS INJECTED WITH BRUCELLA ABORTUS.

Authors:  J S YOUNGNER; W R STINEBRING
Journal:  Science       Date:  1964-05-22       Impact factor: 47.728

2.  Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.

Authors:  D A Stringfellow
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  N,N-dioctadecyl-N',N'-bis(2-hydroxyethyl) propanediamine: antiviral activity and interferon stimulation in mice.

Authors:  W W Hoffman; J J Korst; J F Niblack; T H Cronin
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

4.  BL-20803, a new, low-molecular-weight interferon inducer.

Authors:  P Siminoff; A M Bernard; V S Hursky; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

5.  Stimulation of murine interferon by a substituted pyrimidine.

Authors:  F R Nichol; S D Weed; G E Underwood
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Tilorone hydrochloride: an oral interferon-inducing agent.

Authors:  D A Stringfellow; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

7.  Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 5. Bis-basic ethers of anthraquinone and bisalkamine esters of anthraquinonedicarboxylic acids.

Authors:  A D Sill; E R Andrews; F W Sweet; J W Hoffman; P L Tiernan; J M Grisar; R W Fleming; G D Mayer
Journal:  J Med Chem       Date:  1974-09       Impact factor: 7.446

8.  Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 2. Tilorone and related bis-basic ethers of fluorenone, fluorenol, and fluorene.

Authors:  E R Andrews; R W Fleming; J M Grisar; J C Kihm; D L Wenstrup; G D Mayer
Journal:  J Med Chem       Date:  1974-08       Impact factor: 7.446

9.  Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 4. Bis-basic sulfonamides of anthraquinone.

Authors:  J M Grisar; K R Hickey; R W Fleming; G D Mayer
Journal:  J Med Chem       Date:  1974-08       Impact factor: 7.446

10.  Tilorone hydrochloride: mode of action.

Authors:  G D Mayer; R F Krueger
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

View more
  7 in total

1.  Effect of interferons (rIFN-alpha 2, rIFN-gamma) on DNA-synthesis and HLA-DR expression in psoriasis.

Authors:  H J Schulze; G Mahrle
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice.

Authors:  D F Smee; H A Alaghamandan; J Gilbert; R A Burger; A Jin; B S Sharma; K Ramasamy; G R Revankar; H B Cottam; W B Jolley
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.

Authors:  D F Smee; J L Morris; J A Leonhardt; J R Mead; A Holy; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

4.  A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily.

Authors:  P Savage; V Horton; J Moore; M Owens; P Witt; M E Gore
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.

Authors:  D F Smee; J H Huffman; A C Gessaman; J W Huggins; R W Sidwell
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

6.  Synthesis and affinity to DNA of phenylbenzoimidazoles and benzoimidazo[1,2-c]quinazolines.

Authors:  Elena A Lyakhova; Yulia A Gusyeva; Julia V Nekhoroshkova; Lev M Shafran; Sergey A Lyakhov
Journal:  Eur J Med Chem       Date:  2009-03-21       Impact factor: 6.514

7.  Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.

Authors:  Kamaljit Singh; Kawaljit Singh; Jan Balzarini
Journal:  Eur J Med Chem       Date:  2013-07-05       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.